MedLife invests EUR 3 million in genetic testing, becoming a leader in personalized medicine in Romania with the aim to improve quality of life.
Delia Niculescu
Current Affairs
foto:shutterstock
Always see our news on Google
MedLife is to launch an innovative genetic testing program, with an initial investment of €3 million, aimed at facilitating access to individual genetic mapping and promoting personalized medicine. The project will involve over 4,000 beneficiaries and will use Illumina NovaSeq X Plus sequencing technology, one of the most advanced in the world. This initiative marks an important transition in the Romanian medical system, aiming at prevention and personalization of treatments according to genetic profile. MedLife, with more than 20 years of experience in genetics, thus confirms its leading role in the field and its commitment to improve the health of the population.
Sources
Premieră în România. MedLife aduce cea mai avansată tehnologie de secvențiere și pregătește un program amplu de testare genetică: “Începând cu luna octombrie, pe teritoriul României se va putea realiza secvențierea întregului genom uman la scară largă”
Secvențierea întregului genom uman la scară largă se va putea face în România, din octombrie - Economica.net
Latest News
23:53
Nicușor Dan stated that he does not intend to dismiss Lucian Pahonțu
23:31
Two Romanians were found shot in their home in Ohio, USA / The main suspect is their former son-in-law, who was found dead in the same house
23:18
Israel bans Jean-Luc Mélenchon from entering, amid his criticism of the war in Gaza: “I never asked to enter”
23:00
A man originally from the Republic of Moldova was found dead in his apartment in Italy after his family had not heard from him for several months
22:51
Bucharest National Research Institute: The Romanian AI Factory could be ready for use in 2027
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
